FEIBA to Optimize Postcardiopulmonary Bypass Hemostasis in Pediatric Cardiac Patients
Status:
Not yet recruiting
Trial end date:
2023-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this research is to understand if the medication called FEIBA helps to stop
bleeding and decrease transfusion of blood products to small children operated on the heart.